Testing new PSA subforms to enhance the accuracy of predicting cancer risk and disease outcome in prostate cancer.
Lilja
Hans
H
D000911:Antibodies, Monoclonal; D006801:Humans; D007118:Immunoassay; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000276:immunology; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D011485:Protein Binding; D012306:Risk; D000514:alpha 1-Antichymotrypsin / Q000097:blood
D000911:Antibodies, Monoclonal; D000514:alpha 1-Antichymotrypsin; D017430:Prostate-Specific Antigen